Aurinia Pharmaceuticals
AUPH
#4865
Rank
S$2.39 B
Marketcap
S$18.18
Share price
-0.31%
Change (1 day)
72.07%
Change (1 year)

Market capitalization of Aurinia Pharmaceuticals (AUPH)

Market cap: S$2.39 Billion

As of February 2026 Aurinia Pharmaceuticals has a market cap of S$2.39 Billion. This makes Aurinia Pharmaceuticals the world's 4865th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Aurinia Pharmaceuticals from 2009 to 2026

End of year Market Cap

Year Marketcap Change
2026S$2.39 B-12.84%
2025S$2.75 B53.62%
2024S$1.79 B5.01%
2023S$1.70 B107.17%
2022S$0.82 B-79.47%
2021S$4.00 B73.87%
2020S$2.30 B-23.99%
2019S$3.03 B281.17%
2018S$0.79 B55.53%
2017S$0.51 B323.98%
2016S$0.12 B5.37%
2015S$0.11 B-23.8%
2014S$0.15 B160.38%
2013S$57.72 M342.66%
2012S$13.03 M-50.75%
2011S$26.47 M-49.34%
2010S$52.25 M79.88%
2009S$29.04 M

End of Day market cap according to different sources

On Feb 19th, 2026 the market cap of Aurinia Pharmaceuticals was reported to be:

S$2.40 Billion
by Nasdaq info icon info icon
S$2.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Regeneron Pharmaceuticals
REGN
S$104.14 B 4,243.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
S$22.74 M-99.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
S$22.18 M-99.07%๐Ÿ‡บ๐Ÿ‡ธ USA